1840. Deputy Ken O'Flynn asked the Minister for Health whether any estimate has been produced of the potential annual Exchequer cost associated with reimbursement of obesity pharmacotherapies under current licensing criteria. [41713/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions under the heading Healthcare Policy.
981 questions match, newest first.
1841. Deputy Ken O'Flynn asked the Minister for Health whether any national eligibility framework, prioritisation framework, or phased access model is under development for obesity pharmacotherapy reimbursement. [41714/26]
1842. Deputy Ken O'Flynn asked the Minister for Health whether multidisciplinary assessment, psychological screening, or behavioural intervention participation will be mandatory prior to reimbursement approval for obesity pharmacotherapies. [41715/26]
1843. Deputy Ken O'Flynn asked the Minister for Health whether any assessment has been undertaken of the long-term fiscal sustainability of reimbursing GLP-1 and dual agonist obesity therapies within the public health system. [41716/26]
1845. Deputy Ken O'Flynn asked the Minister for Health whether any estimate has been produced of the projected number of adolescent patients who could potentially meet the proposed reimbursement criteria for semaglutide. [41718/26]
1859. Deputy Colm Burke asked the Minister for Health whether she intends to use Ireland’s Presidency of the Council of the EU in 2026 to advance a renewed EU-level political commitment on HIV prevention, building on the legacy of the Dublin Declaration of 2004; and if she will make a statement on the matter. [41766/26]
1860. Deputy Colm Burke asked the Minister for Health whether HIV prevention will be considered as part of Ireland’s health priorities during its Presidency of the Council of the EU in 2026, building on the legacy of the 2004 Presidency’s Dublin Declaration, particularly in the context of the EU-wide goal of ending HIV as a public health threat by 2030; and if she will make a statement on the matter. [41767/26]
1861. Deputy Colm Burke asked the Minister for Health whether Ireland will support the development of a renewed EU HIV/AIDS Action Plan, given that the previous EU action plan lapsed in 2016; and whether this issue will be raised during Ireland’s Presidency of the Council of the EU in 2026, building on the legacy of the 2004 Presidency’s Dublin Declaration. [41768/26]
1862. Deputy Colm Burke asked the Minister for Health the steps Ireland will take during its Presidency of the Council of the EU to support improved access across Europe to HIV prevention tools, including testing, PrEP, community-led services and stigma-free care; and if she will make a statement on the matter. [41769/26]
1871. Deputy Roderic O'Gorman asked the Minister for Health for a timeline on the skyclarys reimbursement negotiations, following the submission of a proposal by an organisation (details supplied) to the HSE's Corporate Pharmaceutical Unit; and if she will make a statement on the matter. [41813/26]
1872. Deputy Duncan Smith asked the Minister for Health whether she has examined the implications of the Children and Family Relationships Act 2015 for Irish citizens who become parents through lawful assisted reproduction abroad; if she accepts that the current legislation may leave children born in such circumstances without legal protections under Irish law; and if she will make a statement on the matter. [41818/2…
1873. Deputy Duncan Smith asked the Minister for Health the steps being taken to amend the Children and Family Relationships Act 2015 to provide for the recognition in Ireland of intended parents of children born abroad through lawful donor assisted reproduction arrangements, in line with Constitutional equality principles and the best interests of the child; and if she will make a statement on the matter. [41819/26]
1875. Deputy Ryan O'Meara asked the Minister for Health for an update on the pricing and reimbursement application for omaveloxolone (skyclarys); if the commercial proposal has been received from the company; and if she will make a statement on the matter. [41821/26]
1903. Deputy Ken O'Flynn asked the Minister for Health to identify the specific unit, division or named office within her Department responsible for governance oversight of the treatment abroad scheme. [41870/26]
1905. Deputy Ken O'Flynn asked the Minister for Health the dates on which the treatment abroad scheme was audited by HSE Internal Audit since 2020; and whether any recommendations were issued following those audits. [41872/26]
1942. Deputy John Paul O'Shea asked the Minister for Health for an update on the delivery of the implementation plan in response to the report entitled the Use of Uro-gynaecological Mesh in Surgical Procedure; and if she will make a statement on the matter. [41923/26]
1968. Deputy Barry Ward asked the Minister for Health the position regarding the approval process for skyclarys as a treatment for friedrich's ataxia; and if she will make a statement on the matter. [41992/26]
1970. Deputy Barry Ward asked the Minister for Health the position regarding the commercial proposal in relation to the approval process for skyclarys as a treatment for friedrich's ataxia; and if she will make a statement on the matter. [41994/26]
1971. Deputy Barry Ward asked the Minister for Health the position regarding a timeline for the approval of skyclarys as a treatment for friedrich's ataxia; and if she will make a statement on the matter. [41995/26]
1972. Deputy Barry Ward asked the Minister for Health the position regarding meetings held between HSE or Department of Health officials with the manufacturers of skyclarys in relation to its' approval process for the treatment for friedrich's ataxia; and if she will make a statement on the matter. [41996/26]
2029. Deputy Ken O'Flynn asked the Minister for Health whether the HSE or Department of Health has engaged with professional regulators, including the Medical Council, Nursing and Midwifery Board of Ireland, CORU, or Dental Council, regarding information-sharing arrangements where registrants are subject to criminal investigation for serious offences; and if she will make a statement on the matter. [42442/26]
2143. Deputy Seán Crowe asked the Minister for Health if the HSE will continue their harm reduction programme of on-site drug analysis and surrender bins at music festivals in 2026. [42959/26]
2163. Deputy Cathal Crowe asked the Minister for Health when the single point of access model will be commenced; and if she will make a statement on the matter. [43052/26]
2173. Deputy John Paul O'Shea asked the Minister for Health for an update on the process to have the drug skyclarys eligible for friedreich's ataxia patients in Ireland; and if she will make a statement on the matter. [43153/26]
2198. Deputy Ken O'Flynn asked the Minister for Health whether her Department's quarterly oversight meetings with the Treatment Abroad Scheme include consideration of governance, patient safety, safeguarding or clinical outcome matters relating to minors, in addition to activity and expenditure. [43248/26]